Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus]

T Fukuoka1, H Domon, M Kakuta

  • 1Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

The Japanese Journal of Antibiotics
|April 1, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic heterogeneity and clinical implications in gastrointestinal neuroendocrine carcinoma: <i>MYC</i> and <i>KRAS</i> as predictive biomarkers.

ESMO gastrointestinal oncology·2026
Same author

A glycomics approach to discover novel renal biomarkers in birds by administration of cisplatin and diclofenac to chickens.

Poultry science·2018
Same author

Relationship of Serum Carnitine Level with Falls and Gait Disturbance in the Elderly.

The Journal of frailty & aging·2017
Same author

Effects of arachidonic acid on FFA4 receptor: Signaling, phosphorylation and internalization.

Prostaglandins, leukotrienes, and essential fatty acids·2017
Same author

Differential Expression and Roles of Secreted Frizzled-Related Protein 5 and the Wingless Homolog Wnt5a in Periodontitis.

Journal of dental research·2017
Same author

Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice.

Journal of periodontal research·2014

The combination of panipenem (PAPM) and vancomycin (VCM) shows synergistic and additive effects against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. This combination enhances bactericidal activity and reduces bacterial cell surface damage.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to conventional antibiotics.
  • Combination antibiotic therapy is a strategy to overcome antimicrobial resistance and enhance treatment efficacy.

Purpose of the Study:

  • To investigate the in vitro and in vivo synergistic effects of panipenem (PAPM) and vancomycin (VCM) against MRSA.
  • To evaluate the bactericidal activity and impact on bacterial cell structures of the PAPM-VCM combination.

Main Methods:

  • Checkerboard titration was used to assess in vitro synergy between PAPM and VCM against 40 MRSA strains.
  • Time-kill assays evaluated bactericidal activity with different addition sequences of PAPM and VCM.

Related Experiment Videos

  • In vivo efficacy was tested in a mixed infection mouse model involving MRSA and Pseudomonas aeruginosa.

    • Main Results:

    • The PAPM-VCM combination demonstrated synergistic effects against 83% of MRSA strains in vitro.
    • The combination exhibited enhanced bactericidal activity compared to VCM alone and induced significant cell surface damage and bacteriolysis.
    • In vivo, the combination therapy showed greater efficacy than monotherapy against mixed MRSA and P. aeruginosa infections in burned mice.

    Conclusions:

    • The combination of panipenem and vancomycin exhibits significant synergistic activity against MRSA, both in vitro and in vivo.
    • This combination therapy offers a promising strategy for treating infections caused by resistant MRSA strains.
    • The observed synergy may be linked to the disruption of bacterial cell wall synthesis and integrity.